2022年10月8日

-广告-扎卡里·鲍格,硅谷风投公司的联合创始人DCVC,不依靠碳补偿投资公司使他们的商业模式工作。这不是思想的一种控诉。沼泽希望碳信贷市场存在,但现在,他们没有这样的监管和验证需要它的地方。芬兰非盈利和启动补偿分析发现,90%的碳捕获项目2021年的白皮书是无效的。——广告——硅谷的风险投资公司DCVC投资于各种气候科技公司,包括地热能、空中甲烷成像,先进核裂变反应堆,面料由菌丝体,废水过滤技术,等等。——广告——但有一个类别的气候技术场景的联合创始人扎卡里·鲍格DCVC不投资于以下几点:碳补偿。“我们真的不承担或希望看到公司使用碳补偿,“Bogg帕洛阿尔托办公室在一次采访中告诉CNBC在9月下旬。“我们不认为公司需要使用碳补偿,使他们的商业模式工作。”——广告——碳抵消证书或凭证,购买一个公司或组织代表每吨二氧化碳排放量的减少,或2205英镑。如果一个公司或组织无法消除温室气体的释放在他们的业务,他们可以购买碳补偿,以弥补他们的排放。 “There have been some studies showing that up to 90% of carbon offsets are completely ineffective – with no impact – which is a tragedy of our time, as large Fortune 500 companies are paying millions of dollars for these carbon offsets, and continues to emit in the meantime,” Bogg told CNBC. “And these offsets are really having zero impact.” The effectiveness of carbon offsets is a controversial issue, but at least a white paper Published in April 2021 from Finnish non-profits and startups Compensate It was found that 90 percent of carbon capture projects were ineffective. Indemnity has a non-profit advocacy arm and a company that sells high quality carbon offsets. For the white paper, Compensate analyzed more than 100 nature-based carbon offsets certified by third-party validators in space. Of the carbon offsets, which compensation considered a failure, 52% were guilty of what was termed “excess” – for example, offset credits sold to protect trees that were never in any danger of being cut down. . Another 16% of the projects analyzed were considered compensation failures because their sustainability was considered to be at risk. For example, coastal restoration projects for mangroves in Bangladesh were put at risk when floods ravaged the country, the compensation said. So, said Bogue of Local California Projects. “There were some forests to the north of here that were the subject of carbon offsets where someone paid millions of dollars not to cut down the forest and – whether it’s legal or not, we can leave that aside – because those forests burned, Bog said. , “So they actually released the carbon that the company was paying to not release and the company emitted.” DCVC does not invest in companies that currently use carbon offsets, but that is not an indictment against the idea. “To be clear, I want them to exist,” Bogg told CNBC. “I want a carbon tax, I want a carbon credit, a carbon offset.” But there isn’t enough transparency or accountability in the industry, Bogg said. According to Bogue, for the industry to stand properly, an agency similar to the United States Food and Drug Administration (FDA) would be needed. “There’s a very set and rigorous process that you need to go through to take a molecule from discovery to and until you’re dosing a human with it: you need to prove that it’s effective. Well, you need to prove it’s non-toxic,” Bogg said. “I would say that the imperative to reduce CO2 is as much as a human health imperative, putting smaller molecules in our bodies. Full stop.” Until then, the industry is uncertain of being a safe place for the money that DCVC invests on behalf of its limited partners, the likes of college endowments and hospitals. “It should be rigorous, and apples to apples and, and verifiable and documentable,” Bogg said. “It’s not where it is today. That’s where we need to get to, but that’s why it’s not worth investing in.” Credit: www.cnbc.com /